I was recently in a pediatrician’s office when I noticed a sticker for Camp Bon Coeur, or “Camp Good Heart.” The camp is in my home state of Louisiana and serves children with heart conditions. It made me think about children with pulmonary hypertension (PH) who can benefit from…
A new partnership aims to incorporate more patient perspectives into the development of medications for pulmonary hypertension (PH). Cereno Scientific will partner with PHA Europe & Global on a patient-centered drug design project. Patient-centered drug development enables people affected by a disease to contribute throughout the development…
Discussion
When I was 12, an infection related to my central line landed me in the hospital. I was being treated at a large teaching center and clearly remember waking up one day to find more than 10 people in the room staring at me and discussing my case. This was…
Top-line results from a Phase 2 trial of TX45, Tectonic Therapeutics’ experimental drug for pulmonary hypertension associated with heart failure with preserved ejection fraction (PH-HFpEF), are expected late this year or early next year, the company said. The trial, APEX…
Discussion
Discussion
Discussion
Discussion
Discussion
Discussion
Get regular updates to your inbox.
